We want to welcome Axeq Technologies to the Genohub family. Axeq has listed high throughput sequencing services if offers on the Genohub next generation sequencing market. Axeq currently has 4 worldwide sites:
- HQ – Axeq USA in Maryland
- Axeq Europe in Amsterdam
- Axeq Asia in Seoul
- Axeq Japan in Tokyo
Macrogen is the parent company of Axeq which has been a phenomenal success in both the scientific services market and in the field of original genetic research. With devotion to molecular biology, cell biology, genetics research, and extensive investment in installations of cutting-edge research tools – including genotyping, Sanger sequencing and next-generation sequencing platforms, Macrogen successfully published numerous articles in leading journals. These include the publication of the first whole genome sequence of a Korean (Nature), and high resolution CNV analysis of the Asian population (Nature Genetics).
Axeq Technologies was formed in early 2011 as a premium brand to offer both scientific services and collaborations to researchers around the world. The company is dedicated to providing a whole new level of service experience based on its ability to provide publication-quality data and 24/7 client support. Currently, Axeq has listed high throughput sequencing services on an Illumina GAIIx instrument. We look forward to matching Axeq with sequencing projects on the Genohub next generation sequencing market.